Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, TG Therapeutics (TGTX) has a market cap of $6.13 billion USD. According to our data, TG Therapeutics is ranked No.2265 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $6.13 B |
30.84%
|
| Dec 31, 2024 | $4.69 B |
76.23%
|
| Dec 29, 2023 | $2.66 B |
44.38%
|
| Dec 30, 2022 | $1.84 B |
-37.74%
|
| Dec 31, 2021 | $2.96 B |
-63.48%
|
| Dec 31, 2020 | $8.10 B |
368.65%
|
| Dec 31, 2019 | $1.73 B |
170.73%
|
| Dec 31, 2018 | $0.64 B |
-50.00%
|
| Dec 29, 2017 | $1.28 B |
76.34%
|
| Dec 30, 2016 | $0.72 B |
-61.02%
|
| Dec 31, 2015 | $1.86 B |
-24.68%
|
| Dec 31, 2014 | $2.47 B |
306.15%
|
| Dec 31, 2013 | $0.61 B |
7.14%
|
| Dec 31, 2012 | $0.57 B |
223.56%
|
| Dec 30, 2011 | $0.18 B |
-97.78%
|
| Dec 31, 2010 | $7.88 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Incyte
INCY
|
$11.31 B |
0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Exelixis
EXEL
|
$10.23 B |
0.000 M
|
USA
|
 Alkermes
ALKS
|
$4.61 B |
-0.000 M
|
Ireland
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
USA
|
 Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
USA
|
| Market Cap | = | TGTX Stock Price | * | TGTX Shares Outstanding |
| = | $39.03 | * | 0.16 B | |
| = | $6.13 B |